LIVE QUOTE
Cigna Corporation CI
Healthcare · Medical - Healthcare Plans · NYSE
$289.61
Market Cap$105.0B
P/E Ratio12.0
Dividend Yield1.50%
Beta0.30
Employees71,295

Investment Thesis

.

Competitive Moat

characterized by significant scale economies and intangible assets, particularly its established brand and comprehensive service portfolio. The integration of its Evernorth and Cigna Healthcare segments creates high switching costs for clients, as transitioning to competitors would require substantial effort and expense. Over the next 5-10 years, this advantage is likely to remain durable, although emerging competitors offering innovative digital health solutions represent a credible threat. Additionally, traditional players in the insurance market are increasingly pivoting towards integrated care models, intensifying competition.

Growth Engine

Future revenue growth for Cigna is expected to stem from both organic avenues and potential acquisitions, particularly as the total addressable market (TAM) for healthcare services continues to expand. The increasing focus on value-based care, coupled with a rising aging population, provides a favorable backdrop for Cigna's Medicare Advantage and supplemental programs. Furthermore, Cigna's investment in digital health solutions through Evernorth positions it well to tap into the growing demand for telehealth and pharmacy services. Market share is likely to increase as Cigna leverages its existing client relationships while expanding into underpenetrated segments.

This analysis is AI-generated using publicly available market data and is for informational purposes only. It does not constitute investment advice. Always conduct your own research before making investment decisions.
Morningstar Investor
Analyst ratings, fair value, moat
Research CI
Robinhood
$0 commission trades
Trade CI
Webull
Extended-hours, options, charts
Trade CI
TradingView
Advanced charts & screeners
Chart CI
We may earn a commission if you open an account through our links, at no extra cost to you.
Loading chart...

Frequently Asked Questions

As of 2026-06-05, CI does not have a P/E ratio listed, which makes it difficult to assess its valuation relative to its earnings. Additionally, without a market cap provided, it's hard to compare its size to other companies in the healthcare sector.
CI does not currently pay a dividend, as there is no dividend yield listed.
CI operates in the Healthcare sector, specifically within the Medical - Healthcare Plans industry.
The market cap for CI is not available in the provided data, but given its position in the healthcare industry, it is likely classified as a mega-cap company if it exceeds $200 billion.
CI's competitors include major companies such as UnitedHealth Group and Anthem, which also operate in the healthcare plans industry.
FAQ generated 2026-06-05

Related Reading

Related Stocks

← View in Stock Screener
Disclaimer: Stock data sourced from Financial Modeling Prep, updated daily. Prices may be delayed. Interactive charts powered by TradingView. This page is for informational and educational purposes only and does not constitute investment advice. We are not licensed financial advisors. Past performance is not indicative of future results. All investments carry risk, including the possible loss of principal. Please consult a qualified professional before making investment decisions.

Privacy Policy · Terms